Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2025/02/081121
CTRI/2025/02/081121
Not yet recruiting
Not Applicable

COMPARATIVE STUDY OF EFFECT OF MARMA CHIKITSA AS ADD-ON THERAPY ON DIABETES MELLITUS TYPE 2 SUBJECTS ON BLOOD SUGAR LEVEL AND QUALITY OF LIFE PARAMETERS”

UPGIASR RAU Jodhpur Rajasthan1 site in 1 country100 target enrollmentStarted: March 3, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
UPGIASR RAU Jodhpur Rajasthan
Enrollment
100
Locations
1
Primary Endpoint
Change in BSL Or any symptoms
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

Diabetes Mellitus is a global problem, and India is likely to be the diabetic capital of the world by 2030.  To address this global issue holistic, integrated approach is the need of the hour. present study is an attempt to see the effect of non-invasive classical Marma therapy (A unique method where a particular point is pressed in a desired way for a fixed time) on Blood Sugar Level or QOL or both.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
30.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Pre diabetic and diabetic 2.Patients who are on same medicine for longer duration.3.Individual which falls under diagnostic criteria.
  • •Already diagnosed cases of pre diabetic and diabetic
  • •individual willing to be registered for study.

Exclusion Criteria

  • •1.Subject having any congenital elbow end wrist joint disorder.
  • •2.Pregnancy, Post Natal Care, Lactating women.
  • •& menstrual phase
  • •Chain smoker, heavy drinker.
  • •4.Subject having monoplegia, paraplegia.
  • •5.other associated condition.
  • •Traumatic, Infective, Neoplastic condition of patient.
  • •7.Individual suffering from infection like viral, bacterial and fungal.
  • •8.Individual who is suffering from any systemic or metabolic disorders (Hypertension, Tuberculosis, Thyroid).

Outcomes

Primary Outcomes

Change in BSL Or any symptoms

Time Frame: 90 days

Secondary Outcomes

  • Changes in quality of life(12 week)

Investigators

Sponsor
UPGIASR RAU Jodhpur Rajasthan
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Anish Kumar Pathak

Sri Sai Institute of Ayurvedic Research and Medicine

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 3 4
Managment of Madhumeha (Diabetes type 2) through Kutjadi Kashaya.
CTRI/2025/02/080421Govt Ayurveda College and Hospital Nipaniya Rewa50
Not yet recruiting
Phase 2/3
The use of Nisha Aamlaki Powder and Brahmi Powder, combined with walking, to manage Type 2 Diabetes.
CTRI/2025/07/090043FIMS SGT University200
Not yet recruiting
Phase 2/3
Effect of a Unani Herbal Medicine Chilbeenj on Blood Sugar Control in Patients with Type 2 Diabetes.
CTRI/2025/12/099559Government of TamilNadu74
Not yet recruiting
Phase 2/3
Evaluation of Synergistic activity of Honey as Anti-Hyperglycemic when given with Triphala Kashaya in Pre-Diabetes.
CTRI/2025/02/080528DR GRAMA SRIRANGARAJU SAHANA60
Not yet recruiting
Phase 2/3
Comparison of efficacy of two ayurveda drugs namely Truptighna dadhemani tablet and Nisha Amalaki churna in the management of Type 2 Diabetes mellitus
CTRI/2025/06/088739Shree swaminarayan ayurvedic college kalol40